{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Dilated cardiomyopathy", "cardioprotective herbal plants", "diagnostic strategies", "heart failure", "pathophysiology", "small animal models"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36734898", "DateCompleted": {"Year": "2023", "Month": "03", "Day": "08"}, "DateRevised": {"Year": "2023", "Month": "03", "Day": "19"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1871529X23666230123122808"], "Journal": {"ISSN": "2212-4063", "JournalIssue": {"Volume": "22", "Issue": "4", "PubDate": {"Year": "2023"}}, "Title": "Cardiovascular & hematological disorders drug targets", "ISOAbbreviation": "Cardiovasc Hematol Disord Drug Targets"}, "ArticleTitle": "A Comprehensive Review of Dilated Cardiomyopathy in Pre-clinical Animal Models in Addition to Herbal Treatment Options and Multi-modality Imaging Strategies.", "Pagination": {"StartPage": "207", "EndPage": "225", "MedlinePgn": "207-225"}, "Abstract": {"AbstractText": ["Dilated cardiomyopathy (DCM) is distinguished by ventricular chamber expansion, systolic dysfunction, and normal left ventricular (LV) wall thickness, and is mainly caused due to genetic or environmental factors; however, its aetiology is undetermined in the majority of patients. The focus of this work is on pathogenesis, small animal models, as well as the herbal medicinal approach, and the most recent advances in imaging modalities for patients with dilated cardiomyopathy. Several small animal models have been proposed over the last few years to mimic various pathomechanisms that contribute to dilated cardiomyopathy. Surgical procedures, gene mutations, and drug therapies are all characteristic features of these models. The pros and cons, including heart failure stimulation of extensively established small animal models for dilated cardiomyopathy, are illustrated, as these models tend to procure key insights and contribute to the development of innovative treatment techniques for patients. Traditional medicinal plants used as treatment in these models are also discussed, along with contemporary developments in herbal therapies. In the last few decades, accurate diagnosis, proper recognition of the underlying disease, specific risk stratification, and forecasting of clinical outcome, have indeed improved the health of DCM patients. Cardiac magnetic resonance (CMR) is the bullion criterion for assessing ventricular volume and ejection fraction in a reliable and consistent direction. Other technologies, like strain analysis and 3D echocardiography, have enhanced this technique's predictive and therapeutic potential. Nuclear imaging potentially helps doctors pinpoint the causative factors of left ventricular dysfunction, as with cardiac sarcoidosis and amyloidosis."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, Punjab, India."}], "LastName": "Kaur", "ForeName": "Navneet", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, Punjab, India."}], "LastName": "Sharma", "ForeName": "Rahul Kumar", "Initials": "RK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, Punjab, India."}], "LastName": "Singh Kushwah", "ForeName": "Ajay", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, Punjab, India."}], "LastName": "Singh", "ForeName": "Nisha", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela, Ropar, Punjab, India."}], "LastName": "Thakur", "ForeName": "Shilpa", "Initials": "S"}], "PublicationTypeList": ["Review", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Cardiovasc Hematol Disord Drug Targets", "NlmUniqueID": "101269160", "ISSNLinking": "1871-529X"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["diagnostic imaging", "drug therapy", "etiology"], "DescriptorName": "Cardiomyopathy, Dilated"}, {"QualifierName": [], "DescriptorName": "Stroke Volume"}, {"QualifierName": [], "DescriptorName": "Heart"}, {"QualifierName": ["complications"], "DescriptorName": "Heart Failure"}, {"QualifierName": [], "DescriptorName": "Ventricular Dysfunction, Left"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Multimodal Imaging"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Brigden W.; Uncommon myocardial diseases; the non-coronary cardiomyopathies. Lancet 1957,270(7007),1243-1249", "ArticleIdList": ["10.1016/S0140-6736(57)90159-9", "13492602"]}, {"Citation": "Elliott P.; Andersson B.; Arbustini E.; Bilinska Z.; Cecchi F.; Charron P.; Dubourg O.; K\u00fchl U.; Maisch B.; McKenna W.J.; Monserrat L.; Pankuweit S.; Rapezzi C.; Seferovic P.; Tavazzi L.; Keren A.; Classification of the cardiomyopathies: A position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2007,29(2),270-276", "ArticleIdList": ["10.1093/eurheartj/ehm342", "17916581"]}, {"Citation": "Pinto Y.M.; Elliott P.M.; Arbustini E.; Adler Y.; Anastasakis A.; B\u00f6hm M.; Duboc D.; Gimeno J.; de Groote P.; Imazio M.; Heymans S.; Klingel K.; Komajda M.; Limongelli G.; Linhart A.; Mogensen J.; Moon J.; Pieper P.G.; Seferovic P.M.; Schueler S.; Zamorano J.L.; Caforio A.L.P.; Charron P.; Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: A position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 2016,37(23),1850-1858", "ArticleIdList": ["10.1093/eurheartj/ehv727", "26792875"]}, {"Citation": "Maron B.J.; Towbin J.A.; Thiene G.; Antzelevitch C.; Corrado D.; Arnett D.; Moss A.J.; Seidman C.E.; Young J.B.; Contemporary definitions and classification of the cardiomyopathies. Circulation 2006,113(14),1807-1816", "ArticleIdList": ["10.1161/CIRCULATIONAHA.106.174287", "16567565"]}, {"Citation": "Towbin J.A.; Lowe A.M.; Colan S.D.; Sleeper L.A.; Orav E.J.; Clunie S.; Messere J.; Cox G.F.; Lurie P.R.; Hsu D.; Canter C.; Wilkinson J.D.; Lipshultz S.E.; Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006,296(15),1867-1876", "ArticleIdList": ["10.1001/jama.296.15.1867", "17047217"]}, {"Citation": "Taylor M.R.G.; Carniel E.; Mestroni L.; Cardiomyopathy, familial dilated. Orphanet J Rare Dis 2006,1(1),27", "ArticleIdList": ["10.1186/1750-1172-1-27", "16839424"]}, {"Citation": "Kaski J.P.; Elliott P.; The classification concept of the ESC working group on myocardial and pericardial diseases for dilated cardiomyopathy. Herz 2007,32(6),446-451", "ArticleIdList": ["10.1007/s00059-007-3045-5", "17882369"]}, {"Citation": "Roura S.; Bayes-Genis A.; Vascular dysfunction in idiopathic dilated cardiomyopathy. Nat Rev Cardiol 2009,6(9),590-598", "ArticleIdList": ["10.1038/nrcardio.2009.130", "19636323"]}, {"Citation": "Westphal E.; Rohrbach S.; Buerke M.; Behr H.; Darmer D.; Silber R.E.; Werdan K.; Loppnow H.; Altered interleukin-1 receptor antagonist and interleukin-18 mRNA expression in myocardial tissues of patients with dilatated cardiomyopathy. Mol Med 2008,14(1-2),55-63", "ArticleIdList": ["10.2119/2007-00058.Westphal", "17948066"]}, {"Citation": "Bott-Fl\u00fcgel L.; Weig H.J.; \u00dchlein H.; Nabauer M.; Laugwitz K.L.; Seyfarth M.; Quantitative analysis of apoptotic markers in human end-stage heart failure. Eur J Heart Fail 2008,10(2),129-132", "ArticleIdList": ["10.1016/j.ejheart.2007.12.013", "18279768"]}, {"Citation": "Jan M.F.; Tajik A.J.; Modern imaging techniques in cardiomyopathies. Circ Res 2017,121(7),874-891", "ArticleIdList": ["10.1161/CIRCRESAHA.117.309600", "28912188"]}, {"Citation": "Rose E.A.; Gelijns A.C.; Moskowitz A.J.; Heitjan D.F.; Stevenson L.W.; Dembitsky W.; Long J.W.; Ascheim D.D.; Tierney A.R.; Levitan R.G.; Watson J.T.; Ronan N.S.; Shapiro P.A.; Lazar R.M.; Miller L.W.; Gupta L.; Frazier O.H.; Desvigne-Nickens P.; Oz M.C.; Poirier V.L.; Meier P.; Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001,345(20),1435-1443", "ArticleIdList": ["10.1056/NEJMoa012175", "11794191"]}, {"Citation": "Yoshioka D.; Li B.; Takayama H.; Garan R.A.; Topkara V.K.; Han J.; Kurlansky P.; Yuzefpolskaya M.; Colombo P.C.; Naka Y.; Takeda K.; Outcome of heart transplantation after bridge-to-transplant strategy using various mechanical circulatory support devices. Interact Cardiovasc Thorac Surg 2017,25(6),918-924", "ArticleIdList": ["10.1093/icvts/ivx201", "29106559"]}, {"Citation": "Hershberger R.E.; Hedges D.J.; Morales A.; Dilated cardiomyopathy: The complexity of a diverse genetic architecture. Nat Rev Cardiol 2013,10(9),531-547", "ArticleIdList": ["10.1038/nrcardio.2013.105", "23900355"]}, {"Citation": "McNally E.M.; Mestroni L.; Dilated cardiomyopathy. Circ Res 2017,121(7),731-748", "ArticleIdList": ["10.1161/CIRCRESAHA.116.309396", "28912180"]}, {"Citation": "Herman D.S.; Lam L.; Taylor M.R.G.; Wang L.; Teekakirikul P.; Christodoulou D.; Conner L.; DePalma S.R.; McDonough B.; Sparks E.; Teodorescu D.L.; Cirino A.L.; Banner N.R.; Pennell D.J.; Graw S.; Merlo M.; Di Lenarda A.; Sinagra G.; Bos J.M.; Ackerman M.J.; Mitchell R.N.; Murry C.E.; Lakdawala N.K.; Ho C.Y.; Barton P.J.R.; Cook S.A.; Mestroni L.; Seidman J.G.; Seidman C.E.; Truncations of titin causing dilated cardiomyopathy. N Engl J Med 2012,366(7),619-628", "ArticleIdList": ["10.1056/NEJMoa1110186", "22335739"]}, {"Citation": "Jacoby D.; McKenna W.J.; Genetics of inherited cardiomyopathy. Eur Heart J 2012,33(3),296-304", "ArticleIdList": ["10.1093/eurheartj/ehr260", "21810862"]}, {"Citation": "Towbin J.A.; Bowles N.; Dilated cardiomyopathy: A tale of cytoskeletal proteins and beyond. J Cardiovasc Electrophysiol 2006,17(8),919-926", "ArticleIdList": ["10.1111/j.1540-8167.2006.00530.x", "16764708"]}, {"Citation": "Bowles N.E.; Bowles K.R.; Towbin J.A.; The \u201cfinal common pathway\u201d hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz 2000,25(3),168-175", "ArticleIdList": ["10.1007/s000590050003", "10904835"]}, {"Citation": "Feng J.; Yan J.; Buzin C.H.; Towbin J.A.; Sommer S.S.; Mutations in the dystrophin gene are associated with sporadic dilated cardiomyopathy. Mol Genet Metab 2002,77(1-2),119-126", "ArticleIdList": ["10.1016/S1096-7192(02)00153-1", "12359139"]}, {"Citation": "Taylor M.R.G.; Slavov D.; Ku L.; Di Lenarda A.; Sinagra G.; Carniel E.; Haubold K.; Boucek M.M.; Ferguson D.; Graw S.L.; Zhu X.; Cavanaugh J.; Sucharov C.C.; Long C.S.; Bristow M.R.; Lavori P.; Mestroni L.; Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 2007,115(10),1244-1251", "ArticleIdList": ["10.1161/CIRCULATIONAHA.106.646778", "17325244"]}, {"Citation": "van Tintelen J.P.; Hofstra R.M.W.; Katerberg H.; Rossenbacker T.; Wiesfeld A.C.P.; du Marchie Sarvaas G.J.; Wilde A.A.M.; van Langen I.M.; Nannenberg E.A.; van der Kooi A.J.; Kraak M.; van Gelder I.C.; van Veldhuisen D.J.; Vos Y.; van den Berg M.P.; High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. Am Heart J 2007,154(6),1130-1139", "ArticleIdList": ["10.1016/j.ahj.2007.07.038", "18035086"]}, {"Citation": "Tsubata S.; Bowles K.R.; Vatta M.; Zintz C.; Titus J.; Muhonen L.; Bowles N.E.; Towbin J.A.; Mutations in the human \u03b4-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000,106(5),655-662", "ArticleIdList": ["10.1172/JCI9224", "10974018"]}, {"Citation": "Barresi R.; Di Blasi C.; Negri T.; Brugnoni R.; Vitali A.; Felisari G.; Salandi A.; Daniel S.; Cornelio F.; Morandi L.; Mora M.; Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations. J Med Genet 2000,37(2),102-107", "ArticleIdList": ["10.1136/jmg.37.2.102", "10662809"]}, {"Citation": "Olson T.M.; Illenberger S.; Kishimoto N.Y.; Huttelmaier S.; Keating M.T.; Jockusch B.M.; Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 2002,105(4),431-437", "ArticleIdList": ["10.1161/hc0402.102930", "11815424"]}, {"Citation": "Pyle W.G.; Solaro R.J.; At the crossroads of myocardial signaling: the role of Z-discs in intracellular signaling and cardiac function. Circ Res 2004,94(3),296-305", "ArticleIdList": ["10.1161/01.RES.0000116143.74830.A9", "14976140"]}, {"Citation": "Vatta M.; Mohapatra B.; Jimenez S.; Sanchez X.; Faulkner G.; Perles Z.; Sinagra G.; Lin J.H.; Vu T.M.; Zhou Q.; Bowles K.R.; Di Lenarda A.; Schimmenti L.; Fox M.; Chrisco M.A.; Murphy R.T.; McKenna W.; Elliott P.; Bowles N.E.; Chen J.; Valle G.; Towbin J.A.; Mutations in Cypher/ZASPin patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003,42(11),2014-2027", "ArticleIdList": ["10.1016/j.jacc.2003.10.021", "14662268"]}, {"Citation": "Mohapatra B.; Jimenez S.; Lin J.H.; Bowles K.R.; Coveler K.J.; Marx J.G.; Chrisco M.A.; Murphy R.T.; Lurie P.R.; Schwartz R.J.; Elliott P.M.; Vatta M.; McKenna W.; Towbin J.A.; Bowles N.E.; Mutations in the muscle LIM protein and \u03b1-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab 2003,80(1-2),207-215", "ArticleIdList": ["10.1016/S1096-7192(03)00142-2", "14567970"]}, {"Citation": "Hayashi T.; Arimura T.; Itoh-Satoh M.; Ueda K.; Hohda S.; Inagaki N.; Takahashi M.; Hori H.; Yasunami M.; Nishi H.; Koga Y.; Nakamura H.; Matsuzaki M.; Choi B.Y.; Bae S.W.; You C.W.; Han K.H.; Park J.E.; Kn\u00f6ll R.; Hoshijima M.; Chien K.R.; Kimura A.; Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol 2004,44(11),2192-2201", "ArticleIdList": ["10.1016/j.jacc.2004.08.058", "15582318"]}, {"Citation": "Caforio A.L.; Pankuweit S.; Arbustini E.; Basso C.; Gimeno-Blanes J.; Felix S.B.; Fu M.; Helio T.; Heymans S.; Jahns R.; Klingel K.; Linhart A.; Maisch B.; McKenna W.; Mogensen J.; Pinto Y.M.; Ristic A.; Schultheiss H.P.; Seggewiss H.; Tavazzi L.; Thiene G.; Yilmaz A.; Charron P.; Elliott P.M.; Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2013,34,2636-2648", "ArticleIdList": ["10.1093/eurheartj/eht210"]}, {"Citation": "Bowles N.E.; Ni J.; Kearney D.L.; Pauschinger M.; Schultheiss H.P.; McCarthy R.; Hare J.; Bricker J.T.; Bowles K.R.; Towbin J.A.; Detection of viruses in myocardial tissues by polymerase chain reaction. J Am Coll Cardiol 2003,42(3),466-472", "ArticleIdList": ["10.1016/S0735-1097(03)00648-X", "12906974"]}, {"Citation": "Bowles N.E.; Bowles K.R.; Towbin J.A.; Viral genomic detection and outcome in myocarditis. Heart Fail Clin 2005,1(3),407-417", "ArticleIdList": ["10.1016/j.hfc.2005.06.011", "17386863"]}, {"Citation": "Li Y.; Heuser J.S.; Cunningham L.C.; Kosanke S.D.; Cunningham M.W.; Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 2006,177(11),8234-8240", "ArticleIdList": ["10.4049/jimmunol.177.11.8234", "17114501"]}, {"Citation": "Escher F.; K\u00fchl U.; Lassner D.; Stroux A.; Westermann D.; Skurk C.; Tsch\u00f6pe C.; Poller W.; Schultheiss H.P.; Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcome. Eur J Heart Fail 2014,16(10),1066-1072", "ArticleIdList": ["10.1002/ejhf.148", "25163698"]}, {"Citation": "Fauchier L.; Babuty D.; Poret P.; Casset-Senon D.; Autret M.L.; Cosnay P.; Fauchier J.P.; Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy. Eur Heart J 2000,21(4),306-314", "ArticleIdList": ["10.1053/euhj.1999.1761", "10653678"]}, {"Citation": "Ewer M.S.; Vooletich M.T.; Durand J.B.; Woods M.L.; Davis J.R.; Valero V.; Lenihan D.J.; Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment. J Clin Oncol 2005,23(31),7820-7826", "ArticleIdList": ["10.1200/JCO.2005.13.300", "16258084"]}, {"Citation": "Figueredo V.M.; Chemical cardiomyopathies: The negative effects of medications and nonprescribed drugs on the heart. Am J Med 2011,124(6),480-488", "ArticleIdList": ["10.1016/j.amjmed.2010.11.031", "21605722"]}, {"Citation": "Ameri P.; Canepa M.; Anker M.S.; Belenkov Y.; Bergler-Klein J.; Cohen-Solal A.; Farmakis D.; L\u00f3pez-Fern\u00e1ndez T.; Lainscak M.; Pudil R.; Ruschitska F.; Seferovic P.; Filippatos G.; Coats A.; Suter T.; Von Haehling S.; Ciardiello F.; de Boer R.A.; Lyon A.R.; Tocchetti C.G.; Cancer diagnosis in patients with heart failure: Epidemiology, clinical implications and gaps in knowledge. Eur J Heart Fail 2018,20(5),879-887", "ArticleIdList": ["10.1002/ejhf.1165", "29464808"]}, {"Citation": "Zamorano J.L.; Lancellotti P.; Rodriguez Mu\u00f1oz D.; Aboyans V.; Asteggiano R.; Galderisi M.; Habib G.; Lenihan D.J.; Lip G.Y.H.; Lyon A.R.; Lopez Fernandez T.; Mohty D.; Piepoli M.F.; Tamargo J.; Torbicki A.; Suter T.M.; 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the esc committee for practice guidelines. Eur Heart J 2016,37(36),2768-2801", "ArticleIdList": ["10.1093/eurheartj/ehw211", "27567406"]}, {"Citation": "Wallace K.B.; Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis. Cardiovasc Toxicol 2007,7(2),101-107", "ArticleIdList": ["10.1007/s12012-007-0008-2", "17652813"]}, {"Citation": "Lebrecht D.; Walker U.A.; Role of mtDNA lesions in anthracycline cardiotoxicity. Cardiovasc Toxicol 2007,7(2),108-113", "ArticleIdList": ["10.1007/s12012-007-0009-1", "17652814"]}, {"Citation": "Wu A.H.; Cardiotoxic drugs: clinical monitoring and decision making. Heart 2008,94(11),1503-1509", "ArticleIdList": ["10.1136/hrt.2007.133876", "18931163"]}, {"Citation": "Carver J.R.; Ng A.; Meadows A.T.; Vaughn D.J.; Cardiovascular late effects and the ongoing care of adult cancer survivors. Dis Manag 2008,11(1),1-6", "ArticleIdList": ["10.1089/dis.2008.111714", "18279108"]}, {"Citation": "Iarussi D.; Auricchio U.; Agretto A.; Murano A.; Giuliano M.; Casale F.; Indolfi P.; Iacono A.; Protective effect of coenzyme q10 on anthracyclines cardiotoxicity: Control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma. Mol Aspects Med 1994,15,s207-s212", "ArticleIdList": ["10.1016/0098-2997(94)90030-2", "7752832"]}, {"Citation": "Silber J.H.; Cnaan A.; Clark B.J.; Paridon S.M.; Chin A.J.; Rychik J.; Hogarty A.N.; Cohen M.I.; Barber G.; Rutkowski M.; Kimball T.R.; Delaat C.; Steinherz L.J.; Zhao H.; Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol 2004,22(5),820-828", "ArticleIdList": ["10.1200/JCO.2004.06.022", "14990637"]}, {"Citation": "Singal P.K.; Iliskovic N.; Doxorubicin-induced cardiomyopathy. N Engl J Med 1998,339(13),900-905", "ArticleIdList": ["10.1056/NEJM199809243391307", "9744975"]}, {"Citation": "van Acker F.A.; van Acker S.A.; Kramer K.; Haenen G.R.; Bast A.; van der Vijgh W.J.; 7-monohydroxyethylrutoside protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week. Clin Cancer Res 2000,6(4),1337-1341", "ArticleIdList": ["10778960"]}, {"Citation": "Masci P.G.; Maestrini V.K.D.; The ESC Textbook of Cardiovascular Medicine 2009"}, {"Citation": "Enkhsaikhan P.; Animal models of cardiomyopathiesAnimal Models of Cardiomyopathies 2019", "ArticleIdList": ["10.5772/intechopen.89033"]}, {"Citation": "Houser S.R.; Margulies K.B.; Murphy A.M.; Spinale F.G.; Francis G.S.; Prabhu S.D.; Animal models of heart failure: A scientific statement from the american heart association. Circ Res 2012,111(1),131-150", "ArticleIdList": ["10.1161/RES.0b013e3182582523"]}, {"Citation": "Recchia F.A.; Lionetti V.; Animal models of dilated cardiomyopathy for translational research. Vet Res Commun 2007,31(S1),35-41", "ArticleIdList": ["10.1007/s11259-007-0005-8", "17682844"]}, {"Citation": "Milani-Nejad N.; Janssen P.M.L.; Small and large animal models in cardiac contraction research: Advantages and disadvantages. Pharmacol Ther 2014,141(3),235-249", "ArticleIdList": ["10.1016/j.pharmthera.2013.10.007", "24140081"]}, {"Citation": "Piacentino V.; Weber C.R.; Chen X.; Weisser-Thomas J.; Margulies K.B.; Bers D.M.; Houser S.R.; Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res 2003,92(6),651-658", "ArticleIdList": ["10.1161/01.RES.0000062469.83985.9B", "12600875"]}, {"Citation": "Pfeffer M.A.; Pfeffer J.M.; Fishbein M.C.; Fletcher P.J.; Spadaro J.; Kloner R.A.; Braunwald E.; Myocardial infarct size and ventricular function in rats. Circ Res 2021,44(4),503-512", "ArticleIdList": ["10.1161/01.res.44.4.503", "428047"]}, {"Citation": "Prabhu S.; Wang, G.; Luo, J.; Gu, Y.; Ping, P.; Chandrasekar, B. \u03b2-Adrenergic receptor blockade modulates Bcl-XS expression and reduces apoptosis in failing myocardium. J Mol Cell Cardiol 2003,35(5),483-493", "ArticleIdList": ["10.1016/S0022-2828(03)00052-X", "12738230"]}, {"Citation": "Hamid T.; Gu Y.; Ortines R.V.; Bhattacharya C.; Wang G.; Xuan Y.T.; Prabhu S.D.; Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation 2009,119(10),1386-1397", "ArticleIdList": ["10.1161/CIRCULATIONAHA.108.802918", "19255345"]}, {"Citation": "Wang G.; Hamid T.; Keith R.J.; Zhou G.; Partridge C.R.; Xiang X.; Kingery J.R.; Lewis R.K.; Li Q.; Rokosh D.G.; Ford R.; Spinale F.G.; Riggs D.W.; Srivastava S.; Bhatnagar A.; Bolli R.; Prabhu S.D.; Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 2010,121(17),1912-1925", "ArticleIdList": ["10.1161/CIRCULATIONAHA.109.905471", "20404253"]}, {"Citation": "Zhang R.; Khoo M.S.C.; Wu Y.; Yang Y.; Grueter C.E.; Ni G.; Price E.E.; Thiel W.; Guatimosim S.; Song L.S.; Madu E.C.; Shah A.N.; Vishnivetskaya T.A.; Atkinson J.B.; Gurevich V.V.; Salama G.; Lederer W.J.; Colbran R.J.; Anderson M.E.; Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 2005,11(4),409-417", "ArticleIdList": ["10.1038/nm1215", "15793582"]}, {"Citation": "Dai S.; Yuan F.; Mu J.; Li C.; Chen N.; Guo S.; Kingery J.; Prabhu S.D.; Bolli R.; Rokosh G.; Chronic AMD3100 antagonism of SDF-1\u03b1-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction. J Mol Cell Cardiol 2010,49(4),587-597", "ArticleIdList": ["10.1016/j.yjmcc.2010.07.010", "20655922"]}, {"Citation": "Tang X.L.; Rokosh G.; Sanganalmath S.K.; Yuan F.; Sato H.; Mu J.; Dai S.; Li C.; Chen N.; Peng Y.; Dawn B.; Hunt G.; Leri A.; Kajstura J.; Tiwari S.; Shirk G.; Anversa P.; Bolli R.; Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 2010,121(2),293-305", "ArticleIdList": ["10.1161/CIRCULATIONAHA.109.871905", "20048209"]}, {"Citation": "Dawn B.; Guo Y.; Rezazadeh A.; Huang Y.; Stein A.B.; Hunt G.; Tiwari S.; Varma J.; Gu Y.; Prabhu S.D.; Kajstura J.; Anversa P.; Ildstad S.T.; Bolli R.; Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 2006,98(8),1098-1105", "ArticleIdList": ["10.1161/01.RES.0000218454.76784.66", "16556872"]}, {"Citation": "Liu X.; Simpson J.A.; Brunt K.R.; Ward C.A.; Hall S.R.R.; Kinobe R.T.; Barrette V.; Tse M.Y.; Pang S.C.; Pachori A.S.; Dzau V.J.; Ogunyankin K.O.; Melo L.G.; Preemptive heme oxygenase-1 gene delivery reveals reduced mortality and preservation of left ventricular function 1 yr after acute myocardial infarction. Am J Physiol Heart Circ Physiol 2007,293(1),H48-H59", "ArticleIdList": ["10.1152/ajpheart.00741.2006", "17322421"]}, {"Citation": "Zolotareva A.G.; Kogan M.E.; Production of experimental occlusive myocardial infarction in mice. Cor Vasa 1978,20(4),308-314", "ArticleIdList": ["729388"]}, {"Citation": "van den Borne S.W.M.; van de Schans V.A.M.; Strzelecka A.E.; Vervoort-Peters H.T.M.; Lijnen P.M.; Cleutjens J.P.M.; Smits J.F.M.; Daemen M.J.A.P.; Janssen B.J.A.; Blankesteijn W.M.; Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc Res 2009,84(2),273-282", "ArticleIdList": ["10.1093/cvr/cvp207", "19542177"]}, {"Citation": "Lindsey M.L.; Bolli R.; Canty J.M.; Du X.J.; Frangogiannis N.G.; Frantz S.; Gourdie R.G.; Holmes J.W.; Jones S.P.; Kloner R.A.; Lefer D.J.; Liao R.; Murphy E.; Ping P.; Przyklenk K.; Recchia F.A.; Schwartz Longacre L.; Ripplinger C.M.; Van Eyk J.E.; Heusch G.; Guidelines for experimental models of myocardial ischemia and infarction. Am J Physiol Heart Circ Physiol 2018,314(4),H812-H838", "ArticleIdList": ["10.1152/ajpheart.00335.2017", "29351451"]}, {"Citation": "Korf-Klingebiel M.; Reboll M.R.; Klede S.; Brod T.; Pich A.; Polten F.; Napp L.C.; Bauersachs J.; Ganser A.; Brinkmann E.; Reimann I.; Kempf T.; Niessen H.W.; Mizrahi J.; Sch\u00f6nfeld H.J.; Iglesias A.; Bobadilla M.; Wang Y.; Wollert K.C.; Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction. Nat Med 2015,21(2),140-149", "ArticleIdList": ["10.1038/nm.3778", "25581518"]}, {"Citation": "Yeang C.; Hasanally D.; Que X.; Hung M.Y.; Stamenkovic A.; Chan D.; Chaudhary R.; Margulets V.; Edel A.L.; Hoshijima M.; Gu Y.; Bradford W.; Dalton N.; Miu P.; Cheung D.Y.; Jassal D.S.; Pierce G.N.; Peterson K.L.; Kirshenbaum L.A.; Witztum J.L.; Tsimikas S.; Ravandi A.; Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospho lipids. Cardiovasc Res 2019,115(1),179-189", "ArticleIdList": ["10.1093/cvr/cvy136", "29850765"]}, {"Citation": "Poncelas M.; Inserte J.; Aluja D.; Hernando V.; Vilardosa U.; Garcia-Dorado D.; Delayed, oral pharmacological inhibition of calpains attenuates adverse post-infarction remodelling. Cardiovasc Res 2017,113(8),950-961", "ArticleIdList": ["10.1093/cvr/cvx073", "28460013"]}, {"Citation": "Hausenloy D.J.; Chilian W.; Crea F.; Davidson S.M.; Ferdinandy P.; Garcia-Dorado D.; van Royen N.; Schulz R.; Heusch G.; The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection. Cardiovasc Res 2019,115(7),1143-1155", "ArticleIdList": ["10.1093/cvr/cvy286", "30428011"]}, {"Citation": "Weinheimer C.J.; Kovacs A.; Evans S.; Matkovich S.J.; Barger P.M.; Mann D.L.; Load-dependent changes in left ventricular structure and function in a pathophysiologically relevant murine model of reversible heart failure. Circ Heart Fail 2018,11(5),e004351", "ArticleIdList": ["10.1161/CIRCHEARTFAILURE.117.004351", "29716898"]}, {"Citation": "Kapur N.K.; Paruchuri V.; Aronovitz M.J.; Qiao X.; Mackey E.E.; Daly G.H.; Ughreja K.; Levine J.; Blanton R.; Hill N.S.; Karas R.H.; Biventricular remodeling in murine models of right ventricular pressure overload. PLoS One 2013,8(7),e70802", "ArticleIdList": ["10.1371/journal.pone.0070802", "23936252"]}, {"Citation": "Urashima T.; Zhao M.; Wagner R.; Fajardo G.; Farahani S.; Quertermous T.; Bernstein D.; Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis. Am J Physiol Heart Circ Physiol 2008,295(3),H1351-H1368", "ArticleIdList": ["10.1152/ajpheart.91526.2007", "18586894"]}, {"Citation": "Rockman H.A.; Ross R.S.; Harris A.N.; Knowlton K.U.; Steinhelper M.E.; Field L.J.; Ross J.; Chien K.R.; Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci 1991,88(18),8277-8281", "ArticleIdList": ["10.1073/pnas.88.18.8277", "1832775"]}, {"Citation": "Riehle C.; Bauersachs J.; Small animal models of heart failure. Cardiovasc Res 2019,115(13),1838-1849", "ArticleIdList": ["10.1093/cvr/cvz161", "31243437"]}, {"Citation": "Rockman H.A.; Wachhorst S.P.; Mao L.; Ross J.; Jr A.N.G.; II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol 1994,266(6),H2468-H2475", "ArticleIdList": ["8024008"]}, {"Citation": "Barrick C.J.; Rojas M.; Schoonhoven R.; Smyth S.S.; Threadgill D.W.; Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 2007,292(5),H2119-H2130", "ArticleIdList": ["10.1152/ajpheart.00816.2006", "17172276"]}, {"Citation": "Takimoto E.; Champion H.C.; Li M.; Belardi D.; Ren S.; Rodriguez E.R.; Bedja D.; Gabrielson K.L.; Wang Y.; Kass D.A.; Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 2005,11(2),214-222", "ArticleIdList": ["10.1038/nm1175", "15665834"]}, {"Citation": "Lewis G.D.; Lachmann J.; Camuso J.; Lepore J.J.; Shin J.; Martinovic M.E.; Systrom D.M.; Bloch K.D.; Semigran M.J.; Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 2007,115(1),59-66", "ArticleIdList": ["10.1161/CIRCULATIONAHA.106.626226", "17179022"]}, {"Citation": "Riehle C.; Abel E.D.; Insulin signaling and heart failure. Circ Res 2016,118(7),1151-1169", "ArticleIdList": ["10.1161/CIRCRESAHA.116.306206", "27034277"]}, {"Citation": "Gomes A.C.; Falc\u00e3o-Pires I.; Pires A.L.; Br\u00e1s-Silva C.; Leite-Moreira A.F.; Rodent models of heart failure: An updated review. Heart Fail Rev 2013,18(2),219-249", "ArticleIdList": ["10.1007/s10741-012-9305-3", "22446984"]}, {"Citation": "Duncker D.J.; Bakkers J.; Brundel B.J.; Robbins J.; Tardiff J.C.; Carrier L.; Animal and in silico models for the study of sarcomeric cardiomyopathies. Cardiovasc Res 2015,105(4),439-448", "ArticleIdList": ["10.1093/cvr/cvv006", "25600962"]}, {"Citation": "Doudna J.A.; Charpentier E.; The new frontier of genome engineering with CRISPR-Cas9. Science 2014,346(6213),1258096", "ArticleIdList": ["10.1126/science.1258096", "25430774"]}, {"Citation": "Hsu P.D.; Lander E.S.; Zhang F.; Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014,157(6),1262-1278", "ArticleIdList": ["10.1016/j.cell.2014.05.010", "24906146"]}, {"Citation": "Suzuki K.; Tsunekawa Y.; Hernandez-Benitez R.; Wu J.; Zhu J.; Kim E.J.; Hatanaka F.; Yamamoto M.; Araoka T.; Li Z.; Kurita M.; Hishida T.; Li M.; Aizawa E.; Guo S.; Chen S.; Goebl A.; Soligalla R.D.; Qu J.; Jiang T.; Fu X.; Jafari M.; Esteban C.R.; Berggren W.T.; Lajara J.; Nu\u00f1ez-Delicado E.; Guillen P.; Campistol J.M.; Matsuzaki F.; Liu G.H.; Magistretti P.; Zhang K.; Callaway E.M.; Zhang K.; Belmonte J.C.I.; In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration. Nature 2016,540(7631),144-149", "ArticleIdList": ["10.1038/nature20565", "27851729"]}, {"Citation": "Ross J.; Dilated cardiomyopathy: Concepts derived from gene deficient and transgenic animal models. Circ J 2002,66(3),219-224", "ArticleIdList": ["10.1253/circj.66.219", "11922267"]}, {"Citation": "Lampreht Tratar U.; Horvat S.; Cemazar M.; Transgenic mouse models in cancer research. Front Oncol 2018,8,268", "ArticleIdList": ["10.3389/fonc.2018.00268", "30079312"]}, {"Citation": "Arber S.; Hunter J.J.; Ross J.; Hongo M.; Sansig G.; Borg J.; Perriard J.C.; Chien K.R.; Caroni P.; MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 1997,88(3),393-403", "ArticleIdList": ["10.1016/S0092-8674(00)81878-4", "9039266"]}, {"Citation": "Kubota T.; McTiernan C.F.; Frye C.S.; Slawson S.E.; Lemster B.H.; Koretsky A.P.; Demetris A.J.; Feldman A.M.; Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 1997,81(4),627-635", "ArticleIdList": ["10.1161/01.RES.81.4.627", "9314845"]}, {"Citation": "Weinstein D.M.; Mihm M.J.; Bauer J.A.; Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J Pharmacol Exp Ther 2000,294(1),396-401", "ArticleIdList": ["10871338"]}, {"Citation": "Robert J.; Long-term and short-term models for studying anthracycline cardiotoxicity and protectors. Cardiovasc Toxicol 2007,7(2),135-139", "ArticleIdList": ["10.1007/s12012-007-0022-4", "17652818"]}, {"Citation": "Shan J.; Kushnir A.; Betzenhauser M.J.; Reiken S.; Li J.; Lehnart S.E.; Lindegger N.; Mongillo M.; Mohler P.J.; Marks A.R.; Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. J Clin Invest 2010,120(12),4388-4398", "ArticleIdList": ["10.1172/JCI32726", "21099118"]}, {"Citation": "Wang Q.D.; Bohlooly M.; Sj\u00f6quist P.O.; Murine models for the study of congestive heart failure: Implications for understanding molecular mechanisms and for drug discovery. J Pharmacol Toxicol Methods 2004,50(3),163-174", "ArticleIdList": ["10.1016/j.vascn.2004.05.005", "15519903"]}, {"Citation": "Angert D.; Berretta R.M.; Kubo H.; Zhang H.; Chen X.; Wang W.; Ogorek B.; Barbe M.; Houser S.R.; Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells. Circ Res 2011,108(10),1226-1237", "ArticleIdList": ["10.1161/CIRCRESAHA.110.239046", "21454756"]}, {"Citation": "Bristow M.R.; Sageman W.S.; Scott R.H.; Billingham M.E.; Bowden R.E.; Kernoff R.S.; Snidow G.H.; Daniels J.R.; Acute and chronic cardiovascular effects of doxorubicin in the dog: The cardiovascular pharmacology of drug-induced histamine release. J Cardiovasc Pharmacol 1980,2(5),487-516", "ArticleIdList": ["10.1097/00005344-198009000-00002", "6157945"]}, {"Citation": "Gorini S.; De Angelis A.; Berrino L.; Malara N.; Rosano G.; Ferraro E.; Chemotherapeutic drugs and mitochondrial dysfunction: focus on doxorubicin, trastuzumab, and sunitinib. Oxid Med Cell Longev 2018,2018,1-15", "ArticleIdList": ["10.1155/2018/7582730", "29743983"]}, {"Citation": "Lother A.; Bergemann S.; Kowalski J.; Huck M.; Gilsbach R.; Bode C.; Hein L.; Inhibition of the cardiac myocyte mineralocorticoid receptor ameliorates doxorubicin-induced cardiotoxicity. Cardiovasc Res 2018,114(2),282-290", "ArticleIdList": ["10.1093/cvr/cvx078", "28430882"]}, {"Citation": "Zhu W.; Reuter S.; Field L.J.; Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity. Cardiovasc Res 2019,115(5),960-965", "ArticleIdList": ["10.1093/cvr/cvy273", "30423020"]}, {"Citation": "Hullin R.; M\u00e9trich M.; Sarre A.; Basquin D.; Maillard M.; Regamey J.; Martin D.; Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity. Cardiovasc Res 2018,114(2),272-281", "ArticleIdList": ["10.1093/cvr/cvx162", "29016737"]}, {"Citation": "Hayward R.; Hydock D.S.; Doxorubicin cardiotoxicity in the rat: an in vivo characterization. J Am Assoc Lab Anim Sci 2007,46(4),20-32", "ArticleIdList": ["17645292"]}, {"Citation": "Matsumura N.; Zordoky B.N.; Robertson I.M.; Hamza S.M.; Parajuli N.; Soltys C.L.M.; Beker D.L.; Grant M.K.; Razzoli M.; Bartolomucci A.; Dyck J.R.B.; Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes. Cardiovasc Res 2018,114(10),1350-1359", "ArticleIdList": ["10.1093/cvr/cvy064", "29566148"]}, {"Citation": "Robert J.; Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: Predictiveness and pitfalls. Cell Biol Toxicol 2007,23(1),27-37", "ArticleIdList": ["10.1007/s10565-006-0142-9", "17041747"]}, {"Citation": "Nakahara T.; Tanimoto T.; Petrov A.D.; Ishikawa K.; Strauss H.W.; Narula J.; Rat model of cardiotoxic drug-induced cardiomyopathy. Methods Mol Biol 2018,1816,221-232", "ArticleIdList": ["10.1007/978-1-4939-8597-5_17", "29987823"]}, {"Citation": "Todorova V.K.; Beggs M.L.; Delongchamp R.R.; Dhakal I.; Makhoul I.; Wei J.Y.; Klimberg V.S.; Transcriptome profiling of peripheral blood cells identifies potential biomarkers for doxorubicin cardiotoxicity in a rat model. PLoS One 2012,7(11),e48398-e14", "ArticleIdList": ["10.1371/journal.pone.0048398", "23209553"]}, {"Citation": "Aygun H.; Gul S.S.; Cardioprotective effect of melatonin and agomelatine on doxorubicin-induced cardiotoxicity in a rat model: An electrocardiographic, scintigraphic and biochemical study. Bratisl Med J 2019,120(4),249-255", "ArticleIdList": ["10.4149/BLL_2019_045", "31023046"]}, {"Citation": "Bar\u0131\u015f, V.\u00d6; Gedikli, E.; Yersal, N.; M\u00fcft\u00fco\u011flu, S.; Erdem, A. Protective effect of taurine against doxorubicin-induced cardiotoxicity in rats: echocardiographical and histological findings. Amino Acids 2019,51(10-12),1649-1655", "ArticleIdList": ["10.1007/s00726-019-02801-7", "31673792"]}, {"Citation": "Chakouri N.; Farah C.; Matecki S.; Amedro P.; Vincenti M.; Saumet L.; Vergely L.; Sirvent N.; Lacampagne A.; Cazorla O.; Screening for in-vivo regional contractile defaults to predict the delayed Doxorubicin Cardiotoxicity in Juvenile Rat. Theranostics 2020,10(18),8130-8142", "ArticleIdList": ["10.7150/thno.47407", "32724462"]}, {"Citation": "Sharma A.; Parikh M.; Shah H.; Gandhi T.; Modulation of nrf2 by quercetin in doxorubicin-treated rats. Heliyon 2020,6(4),e03803", "ArticleIdList": ["10.1016/j.heliyon.2020.e03803"]}, {"Citation": "Fraccarollo D.; Berger S.; Galuppo P.; Kneitz S.; Hein L.; Sch\u00fctz G.; Frantz S.; Ertl G.; Bauersachs J.; Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction. Circulation 2011,123(4),400-408", "ArticleIdList": ["10.1161/CIRCULATIONAHA.110.983023", "21242479"]}, {"Citation": "Frantz S.; Hofmann U.; Fraccarollo D.; Sch\u00e4fer A.; Kranepuhl S.; Hagedorn I.; Nieswandt B.; Nahrendorf M.; Wagner H.; Bayer B.; Pachel C.; Sch\u00f6n M.P.; Kneitz S.; Bobinger T.; Weidemann F.; Ertl G.; Bauersachs J.; Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction. FASEB J 2013,27(3),871-881", "ArticleIdList": ["10.1096/fj.12-214049", "23159933"]}, {"Citation": "Galuppo P.; Vettorazzi S.; H\u00f6velmann J.; Scholz C.J.; Tuckermann J.P.; Bauersachs J.; Fraccarollo D.; The glucocorticoid receptor in monocyte\u2010derived macrophages is critical for cardiac infarct repair and remodeling. FASEB J 2017,31(11),5122-5132", "ArticleIdList": ["10.1096/fj.201700317R", "28768721"]}, {"Citation": "Thackeray J.T.; Hupe H.C.; Wang Y.; Bankstahl J.P.; Berding G.; Ross T.L.; Bauersachs J.; Wollert K.C.; Bengel F.M.; Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction. J Am Coll Cardiol 2018,71(3),263-275", "ArticleIdList": ["10.1016/j.jacc.2017.11.024", "29348018"]}, {"Citation": "Thum T.; Gross C.; Fiedler J.; Fischer T.; Kissler S.; Bussen M.; Galuppo P.; Just S.; Rottbauer W.; Frantz S.; Castoldi M.; Soutschek J.; Koteliansky V.; Rosenwald A.; Basson M.A.; Licht J.D.; Pena J.T.R.; Rouhanifard S.H.; Muckenthaler M.U.; Tuschl T.; Martin G.R.; Bauersachs J.; Engelhardt S.; MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008,456(7224),980-984", "ArticleIdList": ["10.1038/nature07511", "19043405"]}, {"Citation": "Hu P.; Zhang D.; Swenson L.; Chakrabarti G.; Abel E.D.; Litwin S.E.; Minimally invasive aortic banding in mice: Effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 2003,285(3),H1261-H1269", "ArticleIdList": ["10.1152/ajpheart.00108.2003", "12738623"]}, {"Citation": "Dart C.H.; Holloszy J.O.; Hypertrophied non-failing rat heart; partial biochemical characterization. Circ Res 1969,25(3),245-253", "ArticleIdList": ["10.1161/01.RES.25.3.245", "4390410"]}, {"Citation": "Dempsey E.C.; Newton A.C.; Mochly-Rosen D.; Fields A.P.; Reyland M.E.; Insel P.A.; Messing R.O.; Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 2000,279(3),L429-L438", "ArticleIdList": ["10.1152/ajplung.2000.279.3.L429", "10956616"]}, {"Citation": "Hahn H.S.; Marreez Y.; Odley A.; Sterbling A.; Yussman M.G.; Hilty K.C.; Bodi I.; Liggett S.B.; Schwartz A.; Dorn G.W.; Protein kinase calpha negatively regulates systolic and diastolic function in pathological hypertrophy. Circ Res 2003,93(11),1111-1119", "ArticleIdList": ["10.1161/01.RES.0000105087.79373.17", "14605019"]}, {"Citation": "Braz J.C.; Gregory K.; Pathak A.; Zhao W.; Sahin B.; Klevitsky R.; Kimball T.F.; Lorenz J.N.; Nairn A.C.; Liggett S.B.; Bodi I.; Wang S.; Schwartz A.; Lakatta E.G.; DePaoli-Roach A.A.; Robbins J.; Hewett T.E.; Bibb J.A.; Westfall M.V.; Kranias E.G.; Molkentin J.D.; PKC-\u03b1 regulates cardiac contractility and propensity toward heart failure. Nat Med 2004,10(3),248-254", "ArticleIdList": ["10.1038/nm1000", "14966518"]}, {"Citation": "Jeong D.; Cha H.; Kim E.; Kang M.; Yang D.K.; Kim J.M.; Yoon P.O.; Oh J.G.; Bernecker O.Y.; Sakata S.; Thu L.T.; Cui L.; Lee Y.H.; Kim D.H.; Woo S.H.; Liao R.; Hajjar R.J.; Park W.J.; PICOT inhibits cardiac hypertrophy and enhances ventricular function and cardiomyocyte contractility. Circ Res 2006,99(3),307-314", "ArticleIdList": ["10.1161/01.RES.0000234780.06115.2c", "16809552"]}, {"Citation": "Kubota T.; Bounoutas G.S.; Miyagishima M.; Kadokami T.; Sanders V.J.; Bruton C.; Robbins P.D.; McTiernan C.F.; Feldman A.M.; Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation 2000,101(21),2518-2525", "ArticleIdList": ["10.1161/01.CIR.101.21.2518", "10831527"]}, {"Citation": "Li Y.Y.; Feng Y.Q.; Kadokami T.; McTiernan C.F.; Draviam R.; Watkins S.C.; Feldman A.M.; Myocardial extracellularmatrix remodeling in transgenic mice overexpressing tumor necrosis factor a can be modulated by anti-tumor necrosis factor a therapy. Proc Natl Acad Sci 2000,97(23),12746-12751", "ArticleIdList": ["10.1073/pnas.97.23.12746", "11070088"]}, {"Citation": "Tachjian A.; Maria V.; Jahangir A.; Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol 2010,55(6),515-525", "ArticleIdList": ["10.1016/j.jacc.2009.07.074", "20152556"]}, {"Citation": "Frishman W.H.; Beravol P.; Carosella C.; Alternative and complementary medicine for preventing and treating cardiovascular disease. Dis Mon 2009,55(3),121-192", "ArticleIdList": ["10.1016/j.disamonth.2008.12.002", "19215737"]}, {"Citation": "Chakraborty P.; Airborne pollen of Bombax ceiba L.: An important source of aeroallergen from India. J Palynol Vol 2017,53,139-147"}, {"Citation": "Nitika G.; Meena A.; Jaspreet N.; Evaluation of physicochemical and preliminary phytochemical studies on the root of Bombax ceiba Linn. Int J Res Ayurveda Pharm 2011,2(3),924-926"}, {"Citation": "Patel S.S.; Verma N.K.; Rathore B.; Nayak G.; Singhai A.K.; Singh P.; Cardioprotective effect of Bombax ceiba flowers against acute adriamycin-induced myocardial infarction in rats. Rev Bras Farmacogn 2011,21(4),704-709", "ArticleIdList": ["10.1590/S0102-695X2011005000090"]}, {"Citation": "Intararuchikul T.; Teerapattarakan N.; Rodsiri R.; Tantisira M.; Wohlgemuth G.; Fiehn O.; Tansawat R.; Effects of Centella asiatica extract on antioxidant status and liver metabolome of rotenone-treated rats using GC-MS. Biomed Chromatogr 2019,33(2),e4395", "ArticleIdList": ["10.1002/bmc.4395", "30242859"]}, {"Citation": "Hamid K.; Ng I.; Tallapragada V.J.; V\u00e1radi L.; Hibbs D.E.; Hanrahan J.; Groundwater P.W.; An investigation of the differential effects of ursane triterpenoids from Centella asiatica, and their semisynthetic analogues, on GABAA receptors. Chem Biol Drug Des 2016,88(3),386-397", "ArticleIdList": ["10.1111/cbdd.12766", "27062315"]}, {"Citation": "Gnanapragasam A.; Kumar Ebenezar K.; Sathish V.; Govindaraju P.; Devaki T.; Protective effect of Centella asiatica on antioxidant tissue defense system against adriamycin induced cardiomyopathy in rats. Life Sci 2004,76(5),585-597", "ArticleIdList": ["10.1016/j.lfs.2004.09.009", "15556170"]}, {"Citation": "Pragada R.R.; Veeravalli K.K.; Chowdary K.P.R.; Routhu K.V.; Cardioprotective activity of Hydrocotyle asiatica L. in ischemia-reperfusion induced myocardial infarction in rats. J Ethnopharmacol 2004,93(1),105-108", "ArticleIdList": ["10.1016/j.jep.2004.03.025", "15182913"]}, {"Citation": "Abbas Z.K.; Saggu S.; Sakeran M.I.; Zidan N.; Rehman H.; Ansari A.A.; Phytochemical, antioxidant and mineral composition of hydroalcoholic extract of chicory (Cichorium intybus L.) leaves. Saudi J Biol Sci 2015,22(3),322-326", "ArticleIdList": ["10.1016/j.sjbs.2014.11.015", "25972754"]}, {"Citation": "Nayeemunnisa; Rani, MK Cardioprotective effects of cichorium intybus in ageing myocardium of albino rats. Curr Sci 2003,84(7),941-943"}, {"Citation": "Mridula K.; Parthibhan S.; Senthil Kumar T.; Rao M.V.; In vitro organogenesis from Tinospora cordifolia (Willd.) Miers \u2014 A highly valuable medicinal plant. S Afr J Bot 2017,113,84-90", "ArticleIdList": ["10.1016/j.sajb.2017.08.003"]}, {"Citation": "Upadhyay A.; Kumar K.; Kumar A.; Mishra H.; Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi) - validation of the Ayurvedic pharmacology through experimental and clinical studies. Int J Ayurveda Res 2010,1(2),112-121", "ArticleIdList": ["10.4103/0974-7788.64405", "20814526"]}, {"Citation": "Ahmed Q.; Gupta N.; Kumar A.; Nimesh S.; Antibacterial efficacy of silver nanoparticles synthesized employing Terminalia arjuna bark extract. Artif Cells Nanomed Biotechnol 2017,45(6),1192-1200", "ArticleIdList": ["10.1080/21691401.2016.1215328", "27684206"]}, {"Citation": "Aqil F.; Ahmad I.; Mehmood Z.; Antioxidant and free radical scavenging properties of twelve traditionally used Indian medicinal plants. Turk J Biol 2006,30(3),177-183"}, {"Citation": "Bishop S.; Liu S.J.; Cardioprotective action of the aqueous extract of Terminalia arjuna bark against toxicity induced by doxorubicin. Phytomedicine 2017,36,210-216", "ArticleIdList": ["10.1016/j.phymed.2017.10.007", "29157817"]}, {"Citation": "Sultan P.; Rasool S.; Hassan Q.P.; PicrorhizakurroaRoyle ex Benth. A plant of diverse pharmacological potential. Ann Phytomed 2017,VI(I),63-67", "ArticleIdList": ["10.21276/ap.2017.6.1.9"]}, {"Citation": "Shukla B.; Visen P.; Patnaik G.; Dhawan B.; Choleretic effect of picroliv, the hepatoprotective principle of Picrorhiza kurroa. Planta Med 1991,57(1),29-33", "ArticleIdList": ["10.1055/s-2006-960010", "2062954"]}, {"Citation": "Anandan R; Rekha RD; Devaki T; Kumar MS; Biochemical studies on the protective effects of Picrorhiza kurroa in experimentally induced hepatitis in rats. J. Clin. Biochem. Nutr., 2000,29,09-17", "ArticleIdList": ["10.3164/jcbn.29.9"]}, {"Citation": "Sharma R.K.; Kotoky R.; Bhattacharyya P.R.; Volatile oil from the leaves of Callistemon lanceolatus D.C. grown in north-eastern India. Flavour Fragrance J 2006,21(2),239-240", "ArticleIdList": ["10.1002/ffj.1564"]}, {"Citation": "Sudhakar M.; Rao C.V.; Rao A.L.; Raju D.B.; Antinociceptive and anti-inflammatory effects of the standardized oil of Indian Callistemon lanceolatus leaves in experimental animals. Acta Pharmaceutica Turcica 2004,46,131-139", "ArticleIdList": ["10.4314/ecajps.v7i1.9706"]}, {"Citation": "Kim J.H.; Byun J.C.; Bandi A.K.R.; Hyun C.G.; Lee N.H.; Compounds with elastase inhibition and free radical scavenging activities from Callistemon lanceolatus. J Med Plants Res 2009,3,914-920", "ArticleIdList": ["10.5897/JMPR.9000404"]}, {"Citation": "Kumar S.; Kumar V.; Prakash O.; Antidiabetic, hypolipidemic and antioxidant activities of Callistemon lanceolatus leaves extract. J Herbs Spices Med Plants 2011,17(2),144-153", "ArticleIdList": ["10.1080/10496475.2011.583139"]}, {"Citation": "Ali N.; Syed W.A.S.; Ahmad B.; Calcium channel blocking activity of fruits of Callistemon citrinus. J Chem Soc Pak 2011,33,245-248"}, {"Citation": "Firoz M.; Bharatesh K.; Nilesh P.; Vijay G.; Tabassum S.; Nilofar N.; Cardioprotective activity of ethanolic extract of Callistemon lanceolatus leaves on doxorubicin-induced cardiomyopathy in rats. Bangladesh J Pharmacol 2011,6(1)", "ArticleIdList": ["10.3329/bjp.v6i1.8154"]}, {"Citation": "Yan Y.X.; Hu X.D.; Chen J.C.; Sun Y.; Zhang X.M.; Qing C.; Qiu M.H.; Cytotoxic triterpenoid alkaloids from Buxus microphylla. J Nat Prod 2009,72(2),308-311", "ArticleIdList": ["10.1021/np800719h", "19133780"]}, {"Citation": "Yu B.; Fang T.H.; L\u00fc G.H.; Xu H.Q.; Lu J.F.; Beneficial effect of cyclovirobuxine D on heart failure rats following myocardial infarction. Fitoterapia 2011,82(6),868-877", "ArticleIdList": ["10.1016/j.fitote.2011.04.016", "21575690"]}, {"Citation": "Hamza A.; Amin A.; Daoud S.; The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats. Cell Biol Toxicol 2008,24(1),63-73", "ArticleIdList": ["10.1007/s10565-007-9016-z", "17520333"]}, {"Citation": "Thomas D.E.; Wheeler R.; Yousef Z.R.; Masani N.D.; The role of echocardiography in guiding management in dilated cardiomyopathy. Eur J Echocardiogr 2009,10(8),iii15-iii21", "ArticleIdList": ["10.1093/ejechocard/jep158", "19889654"]}, {"Citation": "Silva Marques J.; Pinto F.J.; Clinical use of multimodality imaging in the assessment of dilated cardiomyopathy. Heart 2015,101(7),565-572", "ArticleIdList": ["10.1136/heartjnl-2013-304539", "24973082"]}, {"Citation": "Francone M.; Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance. ISRN Radiol 2014,2014,1-16", "ArticleIdList": ["10.1155/2014/365404", "24967294"]}, {"Citation": "Lang R.M.; Badano L.P.; Mor-Avi V.; Afilalo J.; Armstrong A.; Ernande L.; Flachskampf F.A.; Foster E.; Goldstein S.A.; Kuznetsova T.; Lancellotti P.; Muraru D.; Picard M.H.; Rietzschel E.R.; Rudski L.; Spencer K.T.; Tsang W.; Voigt J.U.; Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015,16(3),233-271", "ArticleIdList": ["10.1093/ehjci/jev014", "25712077"]}, {"Citation": "O\u2019Gara P.T.; Grayburn P.A.; Badhwar V.; Afonso L.C.; Carroll J.D.; Elmariah S.; Kithcart A.P.; Nishimura R.A.; Ryan T.J.; Schwartz A.; Stevenson L.W.; 2017 ACC expert consensus decision pathway on the management of mitral regurgitation. J Am Coll Cardiol 2017,70(19),2421-2449", "ArticleIdList": ["10.1016/j.jacc.2017.09.019", "29055505"]}, {"Citation": "Rossi A.; Dini F.L.; Faggiano P.; Agricola E.; Cicoira M.; Frattini S.; Simioniuc A.; Gullace M.; Ghio S.; Enriquez-Sarano M.; Temporelli P.L.; Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 2011,97(20),1675-1680", "ArticleIdList": ["10.1136/hrt.2011.225789", "21807656"]}, {"Citation": "Jenkins C.; Bricknell K.; Hanekom L.; Marwick T.H.; Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol 2004,44(4),878-886", "ArticleIdList": ["10.1016/j.jacc.2004.05.050", "15312875"]}, {"Citation": "Ghio S.; Recusani F.; Klersy C.; Sebastiani R.; Laudisa M.L.; Campana C.; Gavazzi A.; Tavazzi L.; Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol 2000,85(7),837-842", "ArticleIdList": ["10.1016/S0002-9149(99)00877-2", "10758923"]}, {"Citation": "Merlo M.; Gobbo M.; Stolfo D.; Losurdo P.; Ramani F.; Barbati G.; Pivetta A.; Di Lenarda A.; Anzini M.; Gigli M.; Pinamonti B.; Sinagra G.; The prognostic impact of the evolution of RV function in idiopathic DCM. JACC Cardiovasc Imaging 2016,9(9),1034-1042", "ArticleIdList": ["10.1016/j.jcmg.2016.01.027", "27344413"]}, {"Citation": "Merlo M.; Caiffa T.; Gobbo M.; Adamo L.; Sinagra G.; Reverse remodeling in dilated cardiomyopathy: Insights and future perspectives. Int J Cardiol Heart Vasc 2018,18,52-57", "ArticleIdList": ["10.1016/j.ijcha.2018.02.005", "29876504"]}, {"Citation": "Merlo M.; Pyxaras S.A.; Pinamonti B.; Barbati G.; Di Lenarda A.; Sinagra G.; Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol 2011,57(13),1468-1476", "ArticleIdList": ["10.1016/j.jacc.2010.11.030", "21435516"]}, {"Citation": "Pitzalis M.V.; Iacoviello M.; Romito R.; Massari F.; Rizzon B.; Luzzi G.; Guida P.; Andriani A.; Mastropasqua F.; Rizzon P.; Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002,40,1615-1622", "ArticleIdList": ["10.1016/S0735-1097(02)02337-9"]}, {"Citation": "Bleeker G.B.; Schalij M.J.; Boersma E.; Holman E.R.; Steendijk P.; van der Wall E.E.; Bax J.J.; Relative merits of M-mode echocardiography and tissue Doppler imaging for prediction of response to cardiac resynchronization therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2007,99(1),68-74", "ArticleIdList": ["10.1016/j.amjcard.2006.07.068", "17196465"]}, {"Citation": "Richardson M.; Freemantle N.; Calvert M.J.; Cleland J.G.F.; Tavazzi L.; Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. Eur Heart J 2007,28(15),1827-1834", "ArticleIdList": ["10.1093/eurheartj/ehm192", "17540848"]}, {"Citation": "McMurray J.J.V.; Adamopoulos S.; Anker S.D.; Auricchio A.; B\u00f6hm M.; Dickstein K.; Falk V.; Filippatos G.; Fonseca C.; Gomez-Sanchez M.A.; Jaarsma T.; K\u00f8ber L.; Lip G.Y.H.; Maggioni A.P.; Parkhomenko A.; Pieske B.M.; Popescu B.A.; R\u00f8nnevik P.K.; Rutten F.H.; Schwitter J.; Seferovic P.; Stepinska J.; Trindade P.T.; Voors A.A.; Zannad F.; Zeiher A.; Bax J.J.; Baumgartner H.; Ceconi C.; Dean V.; Deaton C.; Fagard R.; Funck-Brentano C.; Hasdai D.; Hoes A.; Kirchhof P.; Knuuti J.; Kolh P.; McDonagh T.; Moulin C.; Popescu B.A.; Reiner Z.; Sechtem U.; Sirnes P.A.; Tendera M.; Torbicki A.; Vahanian A.; Windecker S.; McDonagh T.; Sechtem U.; Bonet L.A.; Avraamides P.; Ben Lamin H.A.; Brignole M.; Coca A.; Cowburn P.; Dargie H.; Elliott P.; Flachskampf F.A.; Guida G.F.; Hardman S.; Iung B.; Merkely B.; Mueller C.; Nanas J.N.; Nielsen O.W.; Orn S.; Parissis J.T.; Ponikowski P.; ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology. developed in collaboration with the heart failure association (hfa) of the ESC. Eur Heart J 2012,33(14),1787-1847", "ArticleIdList": ["10.1093/eurheartj/ehs104", "22611136"]}, {"Citation": "Japp A.G.; Gulati A.; Cook S.A.; Cowie M.R.; Prasad S.K.; The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol 2016,67(25),2996-3010", "ArticleIdList": ["10.1016/j.jacc.2016.03.590", "27339497"]}, {"Citation": "Strohm O.; Schulz-Menger J.; Pilz B.; Osterziel K.J.; Dietz R.; Friedrich M.G.; Measurement of left ventricular dimensions and function in patients with dilated cardiomyopathy. J Magn Reson Imaging 2001,13(3),367-371", "ArticleIdList": ["10.1002/jmri.1052", "11241808"]}, {"Citation": "Iles L.M.; Ellims A.H.; Llewellyn H.; Hare J.L.; Kaye D.M.; McLean C.A.; Taylor A.J.; Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. Eur Heart J Cardiovasc Imaging 2015,16(1),14-22", "ArticleIdList": ["10.1093/ehjci/jeu182", "25354866"]}, {"Citation": "Schalla S.; Bekkers S.C.; Dennert R.; van Suylen R.J.; Waltenberger J.; Leiner T.; Wildberger J.; Crijns H.J.; Heymans S.; Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: Comparison of magnetic resonance imaging with right ventricular biopsy. Eur J Heart Fail 2010,12(3),227-231", "ArticleIdList": ["10.1093/eurjhf/hfq004", "20156939"]}, {"Citation": "McCrohon J.A.; Moon J.C.C.; Prasad S.K.; McKenna W.J.; Lorenz C.H.; Coats A.J.S.; Pennell D.J.; Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003,108(1),54-59", "ArticleIdList": ["10.1161/01.CIR.0000078641.19365.4C", "12821550"]}, {"Citation": "de Leeuw N.; Ruiter D.J.; Balk A.H.M.M.; de Jonge N.; Melchers W.J.G.; Galama J.M.D.; Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int 2001,14(5),299-306", "ArticleIdList": ["10.1007/s001470100339", "11692213"]}, {"Citation": "Soriano C.J.; Ridocci F.; Estornell J.; Jimenez J.; Martinez V.; de Velasco J.A.; Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. J Am Coll Cardiol 2005,45(5),743-748", "ArticleIdList": ["10.1016/j.jacc.2004.11.037", "15734620"]}, {"Citation": "Assomull R.G.; Shakespeare C.; Kalra P.R.; Lloyd G.; Gulati A.; Strange J.; Bradlow W.M.; Lyne J.; Keegan J.; Poole-Wilson P.; Cowie M.R.; Pennell D.J.; Prasad S.K.; Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation 2011,124(12),1351-1360", "ArticleIdList": ["10.1161/CIRCULATIONAHA.110.011346", "21900085"]}, {"Citation": "Mahrholdt H.; Wagner A.; Judd R.M.; Sechtem U.; Kim R.J.; Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005,26(15),1461-1474", "ArticleIdList": ["10.1093/eurheartj/ehi258", "15831557"]}, {"Citation": "Kim W.Y.; Danias P.G.; Stuber M.; Flamm S.D.; Plein S.; Nagel E.; Langerak S.E.; Weber O.M.; Pedersen E.M.; Schmidt M.; Botnar R.M.; Manning W.J.; Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001,345(26),1863-1869", "ArticleIdList": ["10.1056/NEJMoa010866", "11756576"]}, {"Citation": "Bruder O.; Schneider S.; Nothnagel D.; Pilz G.; Lombardi M.; Sinha A.; Wagner A.; Dill T.; Frank H.; van Rossum A.; Schwitter J.; Nagel E.; Senges J.; Sabin G.; Sechtem U.; Mahrholdt H.; Acute adverse reactions to gadolinium-based contrast agents in CMR: multicenter experience with 17,767 patients from the EuroCMR Registry. JACC Cardiovasc Imaging 2011,4(11),1171-1176", "ArticleIdList": ["10.1016/j.jcmg.2011.06.019", "22093267"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "26"}, {"Year": "2022", "Month": "11", "Day": "5"}, {"Year": "2022", "Month": "11", "Day": "17"}, {"Year": "2023", "Month": "2", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "3", "Hour": "10", "Minute": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36734898", "10.2174/1871529X23666230123122808", "CHDDT-EPUB-129015"]}}], "PubmedBookArticle": []}